Loading…
Replimune Group, Inc. is projected to rise to $13.80 by 2027, a +26% move from its current price of $10.99. REPL is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/12/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 14 | $10.40 | $10.99 | $11.62 | +0.04% |
| Jul 15 | $10.17 | $11.00 | $11.90 | +0.08% |
| Jul 16 | $9.99 | $11.00 | $12.12 | +0.12% |
| Jul 17 | $9.85 | $11.01 | $12.30 | +0.16% |
| Jul 18 | $9.72 | $11.01 | $12.47 | +0.19% |
| Jul 19 | $9.61 | $11.02 | $12.62 | +0.23% |
| Jul 20 | $9.51 | $11.02 | $12.77 | +0.27% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $9.51 | $11.02 | $12.77 | +0.27% |
| Week 2 | $8.97 | $11.05 | $13.61 | +0.55% |
| Week 3 | $8.59 | $11.08 | $14.30 | +0.82% |
| Week 4 | $8.28 | $11.11 | $14.91 | +1.10% |
| Week 5 | $8.02 | $11.14 | $15.48 | +1.37% |
| Week 6 | $7.79 | $11.17 | $16.02 | +1.65% |
| Week 7 | $7.59 | $11.20 | $16.53 | +1.93% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Replimune Group, Inc. is a clinical-stage biotechnology company focused on the development and commercialization of oncolytic immunotherapies to treat cancer.
Its lead product candidate is RP1, a selectively replicating version of HSV-1 that expresses GALV-GP R(-) and human GM-CSF for a range of solid tumors.
The company is also developing RP2 that express an anti-CTLA-4 antibody-like protein to block the inhibition of the immune response otherwise caused by CTLA-4; and RP3, which express immune-activating proteins that stimulate T cells. Replimune Group, Inc. was founded in 2015 and is headquartered in Woburn, Massachusetts.
REPL currently trades at $11.18 with a market cap of $923.16M and a market rank of 2443.
The thirty-day range runs from $6.58 to $19.01, reflecting ongoing volatility with a bullish technical backdrop.
RSI(14) is 70, SMA50 is $5.35, and SMA200 is $7.08, with support at $3.74 and resistance at $11.18.
Forecasts project a rising average price path over time, with 2026 avg $11.18, 2027 avg $13.67, 2028 avg $14.40, 2029 avg $16.09, 2030 avg $18.90, and 2040 avg $90.63 plus 2050 avg $141.83.
A major floor 84.5% below — a decisive break under it would weaken the trend.
The nearest floor, 57.4% below — buyers have tended to step in here.
The nearest ceiling, 5.8% above — a clean break opens room to run.
A major ceiling 46.0% above — clearing it would confirm fresh momentum.
Key REPL support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of REPL market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $11.24 | Sell | $11.16 | Sell |
| MA 10 | $11.29 | Sell | $11.10 | Sell |
| MA 20 | $10.67 | Buy | $10.50 | Buy |
| MA 50 | $7.65 | Buy | $8.72 | Buy |
| MA 100 | $6.93 | Buy | $7.78 | Buy |
| MA 200 | $7.47 | Buy | $7.66 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 62.15 | Neutral |
| Stoch RSI (14) | 0.00 | Buy |
| CCI (20) | 25.17 | Neutral |
| Williams %R (14) | -100.00 | Info |
| MACD (12,26,9) | -0.20 | Sell |
| ROC (12) | -3.77 | Sell |
| Bollinger %B (20,2) | 0.58 | Neutral |
| Stochastic %K (14) | 0.00 | Buy |
| TRIX (15) | 2.05 | Buy |
| Awesome (5,34) | 1.83 | Buy |
| Ultimate (7,14,28) | 52.84 | Neutral |
| Momentum (10) | -0.14 | Sell |
| Aroon Osc (25) | 44.00 | Buy |
| Hull MA (9) | 11.10 | Sell |
| ADX (14) | 35.11 | Buy |
| ATR (14) | 0.32 | Info |
The 30-day picture shows bullish sentiment with RSI(14) at 70. The price has traded around SMA50 of $5.35 and SMA200 of $7.08, framing a positive near-term trend.
Support sits at $3.74 and resistance at $11.18, while the 30-day range spans $6.58 to $19.01; volatility runs high at approximately 200%.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $1.70 | $10.99 | $14.41 | 0% | Neutral | |
| $10.01 | $13.80 | $20.56 | +26% | Bullish | |
| $9.53 | $13.97 | $22.18 | +27% | Bullish | |
| $10.39 | $16.03 | $26.72 | +46% | Bullish | |
| $12.16 | $19.67 | $34.14 | +79% | Bullish | |
| $14.28 | $24.14 | $43.36 | +120% | Bullish | |
| $21.27 | $37.51 | $69.48 | +241% | Bullish | |
| $22.73 | $41.75 | $79.48 | +280% | Bullish | |
| $19.81 | $37.85 | $73.88 | +244% | Bullish | |
| $23.03 | $45.72 | $91.33 | +316% | Bullish | |
| $41.58 | $92.39 | $202.81 | +741% | Bullish | |
| $65.63 | $145.85 | $335.46 | +12.3x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $1.70 | $10.99 | $13.20 | +0.00% |
| August 2026 | $9.06 | $10.97 | $13.84 | -0.18% |
| September 2026 | $9.27 | $11.39 | $14.67 | +3.80% |
| October 2026 | $8.80 | $10.94 | $14.33 | -3.95% |
| November 2026 | $8.24 | $10.36 | $13.77 | -5.32% |
| December 2026 | $8.43 | $10.70 | $14.41 | +3.31% |
Click any year to see its month-by-month REPL forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Replimune Group, Inc.'s 2026 outlook centres on $10.99, within a $1.70 to $14.41 range. That marks a 0% change versus current levels. Price action looks broadly range-bound.
By 2027, REPL could reach as high as $20.56, with a base case around $13.80 and support toward $10.01 — roughly +26% from $10.99. Buyers look set to stay in control over this stretch.
Expect REPL to range from $9.53 to $22.18 through 2028. The $13.97 average target implies a +27% move from current prices. That is up +1% on the projected 2027 average. Momentum favours further upside here.
The REPL price prediction for 2029 points to an average of $16.03 (low $10.39, high $26.72) — a potential gain of +46% on today's $10.99. Buyers look set to stay in control over this stretch.
In 2030, REPL is projected to trade between $12.16 and $34.14, averaging $19.67 — a potential gain of +79% from today's $10.99. That is up +23% on the projected 2029 average. Momentum favours further upside here.
Replimune Group, Inc.'s 2031 outlook centres on $24.14, within a $14.28 to $43.36 range. That is up +23% on the projected 2030 average. That marks a +120% change versus current levels. Buyers look set to stay in control over this stretch.
By 2032, REPL could reach as high as $69.48, with a base case around $37.51 and support toward $21.27 — roughly +241% from $10.99. Momentum favours further upside here.
Expect REPL to range from $22.73 to $79.48 through 2033. The $41.75 average target implies a +280% move from current prices. That is up +11% on the projected 2032 average. Buyers look set to stay in control over this stretch.
The REPL price prediction for 2034 points to an average of $37.85 (low $19.81, high $73.88) — a potential gain of +244% on today's $10.99. Momentum favours further upside here.
In 2035, REPL is projected to trade between $23.03 and $91.33, averaging $45.72 — a potential gain of +316% from today's $10.99. That is up +21% on the projected 2034 average. Buyers look set to stay in control over this stretch.
Replimune Group, Inc.'s 2040 outlook centres on $92.39, within a $41.58 to $202.81 range. That is up +102% on the projected 2035 average. That marks a +741% change versus current levels. Momentum favours further upside here.
By 2050, REPL could reach as high as $335.46, with a base case around $145.85 and support toward $65.63 — roughly +12.3x from $10.99. Buyers look set to stay in control over this stretch.
Investing $1,000 in REPL today (≈ 90.991811 REPL) could be worth
$13,271.5
+$12,271.5 (+1227%) by 2050 · US Dollar
Based on the average projected REPL price of $145.85 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in REPLwould be worth at today's price.
$1,000 invested in REPL on Jul 10, 2025 (≈ 92.850507 REPL) would be worth
$1,020.43
+$20.43 (+2.0%) today · 1.02× · US Dollar
Based on a REPL entry price of $10.77 vs. today's $10.99.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $11.58 | $949.05 | -5.1% |
| 1 month ago | $8.47 | $1,297.52 | +29.8% |
| 3 months ago | $4.76 | $2,308.82 | +130.9% |
| 6 months ago | $8.1 | $1,355.95 | +35.6% |
| 1 year ago | $10.77 | $1,020.43 | +2.0% |
| All time (5.0y) ago | $33.24 | $330.63 | -66.9% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our REPL forecast.
Our base-case forecast reaches $22.00 around 2031.
Implied market cap at $22.00: $1.85B
The multi-year forecast points to a continued bullish trajectory.
By 2030 the average price is forecast at $18.90 with a ROI of 69.1%, having moved from a min of $11.66 to a max of $32.87.
In 2040 the average is projected at $90.63 with a ROI of 710.7% and a min of $40.78 and max of $199.12.
By 2050 the average is seen at $141.83 with a ROI of 1168.6% and a min of $63.82 and max of $326.21. Sentiment remains BULLISH across these longer horizons, though these are estimates, not guarantees, and subject to change.
Tap a question to reveal the answer.
2030 forecast: avg $18.90, min $11.66, max $32.87, ROI 69.1%, sentiment BULLISH.
Forecasts show bullish sentiment from 2027 onward with rising averages and positive ROI through 2050 (e.g., 2027 avg $13.67; 2030 avg $18.90; 2040 avg $90.63; 2050 avg $141.83; ROI up to 1,168.6%), but these are estimates, not guarantees.
Yes. The forecast max reaches $199.12 in 2040 and $326.21 in 2050, indicating a path that exceeds $100 by later horizons (2040 onward).
The 30-day range is $6.58 to $19.01.
Replimune Group, Inc. Community Discussion
0Share your Replimune Group, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.